Live attenuated simian immunodeficiency virus prevents superinfection by cloned SIVmac251 in cynomolgus monkeys

Journal of General Virology

Volumn 78, Issue 10, 1997, Pages 2529-2539

  Titti, F ^a   Sernicola, L ^a   Geraci, A ^a   Panzini, G ^a   Di Fabio, S ^a   Belli, R ^a   Monardo, F ^b   Borsetti, A ^a   Maggiorella, M T ^a   Koanga Mogtomo, M ^a   Corrias, F ^a   Zamarchi, R ^c   Amadori, A ^c   Chieco Bianchi, L ^c   Verani, P ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 15; INTERLEUKIN 2; MESSENGER RNA; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; BONE MARROW; CONTROLLED STUDY; LYMPH NODE CELL; LYMPHOCYTE COUNT; LYMPHOID HYPERPLASIA; MACACA; MONONUCLEAR CELL; NONHUMAN; PERSISTENT VIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; SUPERINFECTION; VIRUS ATTENUATION; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS ISOLATION;

ANIMALIA; MACACA; MACACA FASCICULARIS; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 15444342817     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-78-10-2529     Document Type: Article

References (49)

1. Ahmad, S., Lohman, M., Marthas, M. L., Giavedoni, L. D., El-Amad, Z., Haigwood, N. L., Scandella, C. J., Gardner, M. B., Luciw, P. A. & Yilma, T. (1994). Reduced viral load in rhesus macaques immunized with recombinant gp160 and challenged with simian immunodeficiency virus. AIDS Research and Human Retroviruses 10, 195-204.
2. Almond, N., Kent, K., Cranage, P. M., Rud, E. W., Clarke, B. & Stott, E. J. (1995). Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet 345, 1342-1344.
3. Amadori, A., Zamarchi, R., Ciminale, V., Del Mistro, A., Siervo, S., Alberti, A., Colombatti, A. & Chieco-Bianchi, L. (1989). HIV-1 specific B cell activation. A major constituent of spontaneous B cell activation during HIV-1 infection. Journal of Immunology 143, 2146-2152.
4. Amadori, A., Zamarchi, R., Veronese, M. L., Panozzo, M., Barelli, A., Borri, A., Sironi, M., Colotta, F., Mantovani, A. & Chieco-Bianchi, L. (1991). B cell activation during HIV-1 infection. II. Cell-to-cell interactions and cytokine requirement. Journal of Immunology 146, 57-62.
5. Armitage, R. J., MacDuff, B. M., Eisenman, J., Paxton, R. & Grabstein, K. H. (1995). IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. Journal of Immunology 154, 483-490.
6. Benveniste, O., Vaslin, B., Le Grand, R., Cheret, A., Matheux, F., Theodore, F., Cranage, M. P. & Dormont, D. (1996). Comparative interleukin (IL)-2/interferon (IFN)-γ and IL-4/IL-10 responses during acute infection of macaques inoculated with attenuated nef-truncated or pathogenic SIVmac251 virus. Proceedings of the National Academy of Sciences, USA 93, 3658-3663.
7. Chomczynsky, P. & Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 162, 156-159.
8. Clements, J. E., Montelaro, R. C., Zink, M. C., Amedee, A. M., Miller, S., Trichel, A. M., Jagerski, B., Hauer, D., Martin, L. N., Bohm, R. P. & Murphey-Corb, M. (1995). Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. Journal of Virology 69, 2737-2744.
9. Daniel, M. D., Kirchhoff, F., Czajak, S. C., Sehgal, P. K. & Desrosiers, R. C. (1992). Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258, 1938-1941.
10. Denesvre, C., Le Grand, R., Boissin-Cans, F., Chakrabarti, L., Hurtrel, B., Vaslin, B., Dormont, D. & Sonigo, P. (1995). Highly attenuated SIVmac142 is immunogenic but does not protect against SIVmac251 challenge. AIDS Research and Human Retroviruses 11, 1397-1406.
11. Desrosiers, R. C., Wyand, M., Kodama, T., Ringler, D. J., Arthur, L. O., Sehgal, P. K., Letvin, N. L., King, N. W. & Daniel, M. D. (1989). Vaccine protection against immunodeficiency virus infection. Proceedings of the National Academy of Sciences, USA 68, 6353-6357.
12. + T cells. International Immunology 6, 11-19.
13. Dittmer, U., Nißlein, T., Bodemer, W., Petry, H., Sauermann, U., Stahl-Hennig, C. & Hunsmann, G. (1995). Cellular immune response of rhesus monkeys with a partially attenuated nef deletion mutant of the simian immunodeficiency virus. Virology 212, 392-397.
14. Dormont, D., Legrand, R., Cranage, P. M., Greenaway, P., Hunsmann, G., Stahl-Hennig, C., Rossi, G. B., Verani, P., Stott, E. J., Kitchin, P., Osterhaus, A., De Vries, P., Kurth, R., Norley, S., Heeney, J., Biberfeld, G. & Putkonen, P. (1995). Protection of macaques against simian immunodeficiency virus infection with inactivated vaccines: comparison of adjuvants, doses, and challenge viruses. Vaccine 15, 295-300.
15. Giavedoni, L. D., Planelles, V., Haigwood, N. L., Ahmad, S., Kluge, J. D., Marthas, M. L., Gardner, M. B., Luciw, P. A. & Yilma, T. D. (1993). Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection. Journal of Virology 67, 577-583.
16. Grabstein, K. H., Eisenman, J., Shanebeck, K., Rauch, C., Srinivasan, S., Fung, V., Beers, C., Richardson, J., Schoenborn, M. A., Ahdieh, M., Johnson, L., Alderson, M. R., Watson, J. D., Anderson, D. M. & Giri, J. G. (1994). Cloning of a T cell growth factor that interacts with the β-chain of the interleukin-2 receptor. Science 264, 965-968.
17. Hart, A. R. & Cloyd, M. W. (1990). Interference patterns of human immunodeficiency viruses HIV-1 and HIV-2. Virology 177, 1-10.
18. Heeney, J. L., Holterman, L., Ten Haaft, P., Dubbes, R., Koornstra, W., Teeuwsen, V., Bourquin, P., Norley, S. & Niphuis, H. (1994). Vaccine protection and reduced virus load from heterologous macaque-propagated SIV challenge. AIDS Research and Human Retroviruses 10, S117-S121.
19. Hu, S. L., Abrams, K., Berber, G. N., Moran, P., Zarling, J. M., Langlois, A. J., Kuller, A. J., Mortan, W. R. & Benveniste, R. E. (1992). Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160. Science 255, 456-459.
20. Hulskotte, E. G., Geretti, A. M., Siebelink, K. H., Van Amerongen, G., Cranage, M. P., Rud, E. W., Norley, S. G., De Vries, P. & Osterhaus, A. D. (1995). Vaccine-induced virus-neutralizing antibodies and cytotoxic T cells do not protect macaques from experimental infection with simian immunodeficiency virus SIVmac32H(J5). Journal of Virology 69, 6289-6296.
21. Israel, Z. R., Edmonson, P. F., Maul, D. H., O'Neil, S. P., Mossman, S. P., Thiriart, C., Fabry, L., Van Opstal, O., Bruck, C., Bex, F., Burny, A., Furtz, P. N., Mullins, J. I. & Hoover, E. A. (1994). Incomplete protection, but suppression of virus burden, elicited by subunit immunodeficiency virus vaccines. Journal of Virology 68, 1843-1853.
22. Kehrl, J. H. & Fauci, A. (1983). Identification, purification and characterization of antigen-activated and antigen-specific human B lymphocytes. Journal of Experimental Medicine 157, 1692-1696.
23. Kestler, H. W., III, Ringler, D. J., Mori, K., Panicali, D. L., Seghal, P. K., Daniel, M. D. & Desrosiers, R. C. (1991). Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651-662.
24. Kieny, M. P., Aubertin, A. M., Benavente, A., Schmitt, D., Dott, K., Beyer, C., Kirn, A., Fisher, F., Hurtrel, B., Rivière, Y., Venet, A. & Mehtali, M. (1993). Protection of monkeys against SIV infection with live attenuated viruses. In Retroviruses of Human AIDS and Related Animal Diseases, pp. 211-218. 8th Cent Gardes Meeting, Marnes-La-Coquette, Paris, France, 25-27 October, 1993.
25. Letvin, N. L. (1993). Vaccine against human immunodeficiency virus -progress and prospects. New England Journal of Medicine 4, 1400-1405.
26. Letvin, N. L., Daniel, M. D., Sehgal, P. K., Desrosiers, R. C., Hunt, R. D., Waldron, L. M., Mackey, J. J., Schmidt, D. K., Chalifoux, L. V. & King, N. W. (1985). Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science 230, 71-73.
27. Lohman, B. L., McChesney, M. B., Miller, C. J., McGowan, E., Joye, S. M., Van Rompay, K. K. A., Reay, E., Antipa, L., Pedersen, N. C. & Marthas, M. L. (1994). A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. Journal of Virology 68, 7021-7029.
28. Marthas, M. L., Sutjipto, S., Higgins, J., Lohman, B. L., Torten, J., Luciw, P. A., Marx, P. A. & Pederson, N. C. (1990). Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV. Journal of Virology 64, 3694-3700.
29. Mills, K. H. G., Page, M. & Kitchin, P. (1993). Immunization of macaques with SIV env recombinants: specificity of T cell and antibody responses and evaluation of protective efficacy. Journal of Medical Primatology 22, 104-109.
30. Mitchell, T. & Risser, R. (1992). Interference established in mice by infection with Friend murine leukemia virus. Journal of Virology 66, 5696-5702.
31. Mori, A., Suko, M., Kaminuma, O., Inoue, S., Ohmura, T., Nishizaki, Y., Nagahori, T., Asakura, Y., Hoshino, A., Okumura, Y., Sato, G., Ito, K. & Okudaira, H. (1996). IL-15 promotes cytokine production on human T helper cells. Journal of Immunology 156, 2400-2405.
32. Murphey-Corb, M., Martin, L. N., Davison-Fairburn, B., Montelaro, R. C., Miller, M., West, M., Ohkawa, S., Baskin, G. B., Zhang, J. Y., Putney, S. D., Allison, A. C. & Eppstein, D. A. (1989). A formalin-inactivated whole SIV vaccine confers protection in macaques. Science 246, 1293-1297.
33. Naidu, M. Y., Kestler, H. W., III, Li, Y., Butler, C. V., Silva, D. P., Schmidt, D. K., Troup, C. D., Sehgal, P. K., Sonigo, P., Daniel, M. D. & Desrosiers, R. C. (1988). Characterization of infectious molecular clones of simian immunodeficiency virus (SIVmac) and human immunodeficiency virus type 2: persistent infection of rhesus monkeys with molecularly cloned SIVmac. Journal of Virology 62, 4691-4696.
34. Norley, S., Beer, B., Binninger-Schinzel, D., Cosma, C. & Kurth, R. (1996). Protection from pathogenic SIVmac challenge following short-term infection with a nef-deficient attenuated virus. Virology 219, 195-205.
35. Prasad, V. R., Myrick, K., Haseltine, W. & Stephen, P. G. (1990). Expression of enzymatically active reverse transcriptase of simian immunodeficiency virus in bacteria: sensitivity to nucleotide analogue inhibitors. Virology 179, 896-900.
36. Putkonen, P., Walther, L., Zhang, Y. J., Li, S. L., Nilsson, C., Albert, J., Biberfeld, P., Thorstensson, R. & Biberfeld, G. (1995). Long-term protection against SIV-induced disease in macaques vaccinated with a live attenuated HIV-2 vaccine. Nature Medicine 1, 914-918.
37. Rose, J., Silvera, P., Flanagan, B., Kitchin, P. & Almond, N. (1995). The development of PCR-based assays for the detection and differentiation of simian immunodeficiency virus in vivo. Journal of Virological Methods 51, 229-240.
38. Rud, E. W., Yon, J. R., Larder, B. A., Clarke, B. E., Cook, N. & Cranage, M. (1992). Infectious molecular clone of SIVmac32H: nef deletion controls ability to re-isolate virus from rhesus macaques. Vaccine 92, 229-235.
39. Rud, E. W., Cranage, M., Yon, J., Quirck, J., Ogilvie, L., Cook, N., Webster, S., Dennis, M. & Clarke, B. E. (1994). Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H provirus clones containing nef size variants. Journal of General Virology 75, 529-543.
40. Saiki, R. K., Scharf, S., Faloona, F., Mullis, K. B., Horn, G. T., Erlich, H. A. & Arnheim, N. (1985). Enzymatic amplification of beta globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230, 1350-1354.
41. Salter, R. D., Howell, D. N. & Cresswell, P. (1985). Genes regulating HLA class-I antigen expression in T-B lymphoblast hybrids. Immunogenetics 21, 235-246.
42. + T cells for IFN-γ but have different effects on priming for IL-4. Journal of Immunology 156, 2413-2422.
43. Stahl-Hennig, C., Voss, G., Dittmer, U., Coulibaly, C., Petry, H., Makoschey, B., Cranage, M. P., Aubertin, A. M., Luke, W. & Hunsman, G. (1993). Protection of monkeys by a split vaccine against SIVmac depends upon biological properties of the challenge virus. Journal of Acquired Immune Deficiency Syndromes 7, 787-795.
44. Stott, E. J. (1991). Anti-cell antibody in macaques. Nature 353, 393.
45. Titti, F., Koanga-Mogtomo, M. L., Borsetti, A., Geraci, A., Sernicola, L., Panzini, G., Turillazzi, G. P., Baroncelli, S., Giovannetti, A., Zamarchi, R., Amadori, A., Dianzani, F., Chieco-Bianchi, L., Rossi, G. B. & Verani, P. (1993). Immunization of Macaca fascicularis with inactivated SIV preparations : a) challenge with human- or monkey-derived SIV; b) effects of a longer immunization schedule. Journal of Medical Primatology 22, 110-118.
46. Titti, F., De Rossi, A., Geraci, A., Masiero, S., Corrias, F., Panzini, L., Sernicola, L., Maggiorella, M. T., Baroncelli, S., Fabiani, M., Amadori, A., Chieco-Bianchi, L. & Verani, P. (1996). Immunotherapy of SIV-infected Macaca fascicularis with an inactivated SIV immunogen. Cellular Pharmacology AIDS Science 3, 123-128.
47. Whatmore, A. M., Cook, N., Hall, G. A., Sharpe, S., Rud, E. W. & Cranage, M. P. (1995). Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence. Journal of Virology 69, 5117-5123.
48. Zamarchi, R., Veronese, M. L., Titti, F., Geraci, A., Verani, P., Rossi, G. B., Amadori, A. & Chieco-Bianchi, L. (1993). In vitro spontaneous production of anti-SIV antibodies is a reliable tool in the follow-up of protection of SIV-vaccinated monkeys. AIDS Research and Human Retroviruses 9, 1139-1144.
49. Zou, W., Lackner, A. A., Simon, M., Durand-Gasselin, I., Galanaud, P., Desrosiers, R. C. & Emilie, D. (1997). Early cytokine and chemokine gene expression in lymph nodes of macaques infected with simian immunodeficiency virus is predictive of disease outcome and vaccine efficacy. Journal of Virology 71, 1227-1236.